Calcipotriene NDC 68462-310

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-310Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0310Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-310-65	68462031065	60 g in 1 TUBE (68462-310-65)Marketed from Mar 24, 2010
68462-310-66	68462031066	1 TUBE in 1 CARTON (68462-310-66) / 120 g in 1 TUBEMarketed from Mar 24, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — 50 ug/g
Dosage form: Ointment
Route: Topical
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090633
Marketing start: Mar 24, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 68462-310_a281edd2-1ec3-440c-9823-1c7541ff8c83SPL ID a281edd2-1ec3-440c-9823-1c7541ff8c83SPL set ID 1bc020e0-b5ae-4cda-aa5b-87fa0452a6bcRxCUI 198373UNII 143NQ3779BUPC 0368462310656
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462031065 followed by a unit qualifier and the quantity

Package 68462-0310-65. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Calcipotriene ointment USP, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090633

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090633
Product	Strength	Form · route	Labeler	Product NDC
Calcitrenecalcipotriene	Calcipotriene .05 mg/g	OintmentTopical	Sun Pharmaceutical Industries, Inc.	51672-5278
Calcipotriene	Calcipotriene .05 mg/g	OintmentTopical	Sun Pharmaceutical Industries, Inc.	51672-4154